Manuel Hermida Prieto

Dr. Manuel Hermida Prieto

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Open access
GMGrecia M. Marrón-Liñares
Grecia M. Marrón-Liñares
Lucía NúñezLucía Núñez
Lucía Núñez
MCMaría G. Crespo-Leiro
María G. Crespo-Leiro
EBEduardo Barge-Caballero
Eduardo Barge-Caballero
JPJorge Pombo
Jorge Pombo
MPManuel Hermida Prieto
Manuel Hermida Prieto
Heart transplantation (HT) is a life-saving treatment for patients with end-stage heart failure. One of the main problems after HT is the humoral response termed antibody-mediated rejection (AMR). Complement activation plays a key role in AMR contributing to graft damage. The aim of this study was to analyze genetic variants in genes related to the complement pathways that could be associated with the development of AMR. Analysis of 51 genes related to the complement pathway was performed by next-generation sequencing in 46 HT recipients, 23 with and 23 without AMR. Statistical analysis was performed with SNPstats and R. We identified 2 single nucleotide polymorphisms, 1 in the mannose-binding lectin 2 gene (p.Gly54Asp-MBL2) and 1 in the complement factor properdin gene (p.Asn428(p=)-CFP), that showed significant association with the absence and development of AMR, respectively. Moreover, the presence of the rare allele in p.Gly54Asp-MBL2 control patients correlated with an immunodeficiency of mannose-binding lectin (6.24 ng/ml vs 207.50 ng/ml, p < 0.01), whereas the presence of the rare allele p.Asn428(p=)-CFP in patients with AMR correlated with higher levels of properdin protein (14.65 μg/ml vs 10.77 μg/ml, p < 0.05). AMR is a complex phenotype affected by many recipient factors. Variants in p.Gly54Asp-MBL2 and p.Asn428(p=)-CFP genes, encoding mannose-binding lectin 2 and properdin, may influence the risk of AMR.

1 January 2018 in Circulation Journal
Verified
Journal Article
Open access
PDF file
GMGrecia M. Marrón-Liñares
Grecia M. Marrón-Liñares
Lucía NúñezLucía Núñez
Lucía Núñez
MCMaría G. Crespo-Leiro
María G. Crespo-Leiro
EÁEloy Álvarez-López
Eloy Álvarez-López
EBEduardo Barge-Caballero
Eduardo Barge-Caballero
MPManuel Hermida Prieto
Manuel Hermida Prieto
Background:Heart transplantation (HT) is a well-established lifesaving treatment for endstage cardiac failure. Antibody-mediated rejection (AMR) represents one of the main problems after HT because of its diagnostic complexity and the poor evidence for supporting treatments. Complement cascade and B-cells play a key role in AMR and contribute to graft damage. This study explored the importance of variants in genes related to complement pathway and B-cell biology in HT and AMR in donors and in donor-recipient pairs.Methods and Results:Genetic variants in 112 genes (51 complement and 61 B-cell biology genes) were analyzed on next-generation sequencing in 28 donor-recipient pairs, 14 recipients with and 14 recipients without AMR. Statistical analysis was performed with SNPStats, R, and EPIDAT3.1. We identified one single nucleotide polymorphism (SNP) in donors in genes related to B-cell biology,interleukin-4 receptor subunitα (p.Ile75Val-IL4Rα), which correlated with the development of AMR. Moreover, in the analysis of recipient-donor genotype discrepancies, we identified another SNP, in this case inadenosine deaminase(ADA; p.Val178(p=)), which was related to B-cell biology, associated with the absence of AMR.Conclusions:Donor polymorphisms and recipient-donor discrepancies in genes related to the biology of B-cells, could have an important role in the development of AMR. In contrast, no variants in donor or in donor-recipient pairs in complement pathways seem to have an impact on AMR.

Verified
Journal Article
Open access
PDF file
RLRoberto Lorente-Bermúdez
Roberto Lorente-Bermúdez
RPRicardo Pan-Lizcano
Ricardo Pan-Lizcano
Lucía NúñezLucía Núñez
Lucía Núñez
DLDomingo López-Vázquez
Domingo López-Vázquez
FRFernando Rebollal-Leal
Fernando Rebollal-Leal
MPManuel Hermida Prieto
Manuel Hermida Prieto
Sudden cardiac death due to ventricular fibrillation (VF) during ST-elevation acute myocardial infarction (STEAMI) significantly contributes to cardiovascular-related deaths. Although VF has been linked to genetic factors, variations in copy number variation (CNV), a significant source of genetic variation, have remained largely unexplored in this context. To address this knowledge gap, this study performed whole exome sequencing analysis on a cohort of 39 patients with STEAMI who experienced VF, aiming to elucidate the role of CNVs in this pathology. The analysis revealed CNVs in the form of duplications in the PARP2 and TTC5 genes as well as CNVs in the form of deletions in the MUC15 and PPP6R1 genes, which could potentially serve as risk indicators for VF during STEAMI. The analysis also underscores notable CNVs with an average gene copy number equal to or greater than four in DEFB134, FCGR2C, GREM1, PARM1, SCG5, and UNC79 genes. These findings provide further insight into the role of CNVs in VF in the context of STEAMI.

23 July 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Lucía NúñezLucía Núñez
Lucía Núñez
GMGrecia M. Marrón-Liñares
Grecia M. Marrón-Liñares
MCMaría G. Crespo-Leiro
María G. Crespo-Leiro
EBEduardo Barge-Caballero
Eduardo Barge-Caballero
EÁEloy Álvarez-López
Eloy Álvarez-López
MPManuel Hermida Prieto
Manuel Hermida Prieto
One of the main problems involved in heart transplantation (HT) is antibody-mediated rejection (AMR). Many aspects of AMR are still unresolved, including its etiology, diagnosis and treatment. In this project, we hypothesize that variants in genes involved in B-cell biology in HT patients can yield diagnostic and prognostic information about AMR. Genetic variants in 61 genes related to B-cell biology were analyzed by next generation sequencing in 46 HT patients, 23 with and 23 without AMR. We identified 3 single nucleotide polymorphisms in ITGA4 gene (c.1845G>A, c.2633A>G, and c.2883C>T) that conformed the haplotype AGT-ITGA4. This haplotype is associated with the development of AMR. Moreover, AMR patients with the haplotype AGT-ITGA4 present lower levels of integrin α-4 in serum samples compared to the reference GAC haplotype in control patients. We can conclude that polymorphisms in genes related to the biology of B-cells could have an important role in the development of AMR. In fact, the AGT haplotype in ITGA4 gene could potentially increase the risk of AMR.

9 November 2018 in Oncotarget
Verified
Journal Article
Open access
GMGrecia M. Marrón-Liñares
Grecia M. Marrón-Liñares
Lucía NúñezLucía Núñez
Lucía Núñez
MPManuel Hermida Prieto
Manuel Hermida Prieto

1 January 2019 in Journal of Stem Cell Research and Medicine
Verified
Journal Article
Open access
LMLuis Antonio Marinas-Pardo
Luis Antonio Marinas-Pardo
LNLaura Núñez-Naveira
Laura Núñez-Naveira
MPManuel Hermida Prieto
Manuel Hermida Prieto
OA Text is an independent open-access scientific publisher showcases innovative research and ideas aimed at improving health by linking research and practice to the benefit of society.